대사증후군과 전립샘특이항원의 상관관계
The Association of Metabolic Syndrome and Prostate-Specific Antigen
윤영은, 이재원, 이석영, 임경택, 박성열, 김용태, 이춘용, 박해영,
소속 상세정보
윤영은 ( Yoon Young-Eun )
한양대학교 의과대학 비뇨기과학교실
이재원 ( Lee Je-Won )
한양대학교 의과대학 비뇨기과학교실
이석영 ( Lee Seok-Young )
한양대학교 의과대학 비뇨기과학교실
임경택 ( Lim Kyoung-Taek )
한양대학교 의과대학 비뇨기과학교실
박성열 ( Park Sung-Yul )
한양대학교 의과대학 비뇨기과학교실
김용태 ( Kim Yong-Tae )
한양대학교 의과대학 비뇨기과학교실
이춘용 ( Lee Tchun-Yong )
한양대학교 의과대학 비뇨기과학교실
박해영 ( Park Hae-Young )
한양대학교 의과대학 비뇨기과학교실
KMID : 0358320090500100963
Abstract
Purpose: Recent studies have reported the association between metabolic syndrome and benign prostatic hyperplasia. This study was conducted to evaluate the relation between metabolic syndrome and prostate-specific antigen (PSA).
Materials and Methods: From January 2004 to December 2007, a total of 4,115 male outpatients (aged 40 to 79 years) who visited the health care center at our medical center were examined. Eligible men were classified according to the presence or absence of metabolic syndrome and the number of components of the metabolic syndrome. The association between the sum of metabolic syndrome components and PSA level was evaluated. The association between each metabolic syndrome component and PSA level was also evaluated.
Results: The PSA level of metabolic syndrome patients was lower than that of the control group (p=0.022). An increased number of metabolic syndrome components was significantly associated with a linear, decreasing trend in PSA levels (p-trend=0.040). When a Pearson’s correlation was performed, only obesity was inversely associated with PSA level in the metabolic syndrome group. There was no significant factor that was related to having a PSA level greater than or equal to 2.5 ng/ml.
Conclusions: Metabolic syndrome should be considered as a factor associated with reduced PSA levels. If the patient with metabolic syndrome is obese, the PSA cutoff value should be lower than 4 ng/ml.
키워드
Prostate-specific antigen;Metabolic syndrome X;Obesity
원문 및 링크아웃 정보
등재저널 정보